Crossmark

Correction to: Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carflzomib and antiCD38 monoclonal antibodies

Crossref DOI link: https://doi.org/10.1007/s00277-025-06333-x

Published Online: 2025-03-31

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Costa, Luciano J. https://orcid.org/0000-0001-5362-2469
Gay, Francesca https://orcid.org/0000-0002-8619-412X
Landgren, Ola https://orcid.org/0000-0001-6485-4839
Mateos, María-Victoria https://orcid.org/0000-0003-2390-1218
Moreau, Philippe https://orcid.org/0000-0003-1780-8746
Touzeau, Cyrille https://orcid.org/0000-0003-0275-2575
Ertel, Franziska https://orcid.org/0009-0006-6970-303X
McFadden, Ian https://orcid.org/0009-0004-7488-8804
Najdi, Rani

Weisel, Katja https://orcid.org/0000-0001-9422-6614
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-31
More Information

Article History

First Online: 31 March 2025